๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Beijing
Clinical trial register · China

Clinical Trials in Beijing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Peking Union Medical College Hospital276 Beijing Tiantan Hospital214 Cancer Institute and Hospital, Chinese Academy of Medical Sciences197 AstraZeneca183 Peking University People's Hospital158
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Beijing

5484 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
HMPL-A830 in Solid Tumors
NCT07718581Solid Tumor, Adult
Hutchmed
Phase 1/2
147
Beijing, Changsha, Chengdu, Guangzhou, Jinan, Nanjing, Taiyuan
2026-08-15
Not yet open
A Phase I/II Study of Eque-cel in Subjects Withimmune-mediated Necrotizing Myopathy
NCT07752264Refractory Immune-mediated Necrotizing Myopathy
Nanjing IASO Biotechnology Co., Ltd.
Phase 1/2
27
Beijing, Zhengzhou, Shanghai, Hangzhou
2026-08-15
Not yet open
TLL-018 in Patients With Moderate to Severe Active Rheumatoid Arthritis With Inadequate Response or Intolerance to csDMARDs
NCT07748728Rheumatoid Arthritis (RA)
Hangzhou Highlightll Pharmaceutical Co., Ltd
Phase 2
90
Beijing
2026-08-14
Recruiting
A Study of HRS-4729 Injection and HRS9531 Injection in Participants With Metabolic Dysfunction-Associated Steatohepatitis
NCT07660848Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 2
160
Beijing, Zhengzhou
2026-08-14
Recruiting
A Randomized Controlled Trial of 3D Airway Reconstruction for Precise Double-Lumen Bronchial Intubation
NCT07719959Pulmonary Nodules
Peking Union Medical College Hospital
Not applicable
174
Beijing
2026-08-14
Recruiting
Study on the Treatment of Adolescent Patients With Seasonal Allergic Rhinitis
NCT07678931Seasonal Allergic Rhinitis (SAR)
Chengdu Kangnuoxing Biopharma,Inc.
Phase 3
136
Beijing, Langfang, Baoding, Cangzhou, Shijiazhuang, Zhangjiakou, Zhengzhou, Baotou
2026-08-13
Recruiting
TROP2 NMR Concordance Study
NCT07624318Lung Cancer
AstraZeneca
Observational
3,400
Beijing, Guangzhou, Shanghai
2026-08-13
Recruiting
A Clinical Study of SHR-4685 on Safety, Tolerability and Pharmacokinetics in Participants With Solid Tumors
NCT07676903Solid Tumor
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1
170
Beijing
2026-08-13
Recruiting
Barriers and Facilitators of Persistence With Adjuvant Osimertinib
NCT07542210Non-small Cell Lung Cancer
AstraZeneca
Observational
100
Beijing
2026-08-13
Recruiting
HSK42360-Na Tablets Combined With Cetuximab With or Without Chemotherapy in BRAF V600-Mutant Metastatic Colorectal Cancer
NCT07790510Metastatic Colorectal Cancer (CRC)
Haisco Pharmaceutical Group Co., Ltd.
Phase 1/2
180
Beijing
2026-08-12
Recruiting
Lenalidomide Plus Targeted Therapy and Immunotherapy for Refractory HCC
NCT07639138Hepatocellular Carcinoma (HCC)
Shunda Du
Phase 2
32
Beijing
2026-08-12
Recruiting
A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of BRII-5395 in Combination With Sintilimab and Bevacizumab in Advanced Hepatitis B Virus Related Hepatocellular Carcinoma
NCT07557251Advanced HBV-Related Hepatocellular Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1
21
Beijing
2026-08-12
Recruiting
A Clinical Study Evaluating the Efficacy and Safety of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis
NCT07688772Seasonal Allergic Rhinitis
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 3
196
Beijing
2026-08-11
By invitation
Smart Analysis and Decision-Making for Emerging Infectious Diseases
NCT07678619Emerging Infectious Diseases, COVID-19, Influenza, Mpox (Monkeypox)
Peking University
Not applicable
108
Beijing
2026-08-10
Not yet open
A Randomized Controlled Trial: Fuzheng Yangxin Formula for ERAS After CABG
NCT07781436CAD - Coronary Artery Disease, CABG, ERAS, Medicine, Chinese Traditional
Peking University Third Hospital
Not applicable
230
Beijing
2026-08-10
Not yet open
Phase II Clinical Study on the Efficacy and Safety of QLS7305 in Patients With Kidney Disease (Part A)
NCT07730632IgAN - IgA Nephropathy, Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN), C3 Glomerulopathy (C3G), Primary Membranous Nephropathy
Qilu Pharmaceutical Co., Ltd.
Phase 2
60
Beijing
2026-08-10
Recruiting
Treatment for "Asymmetric Crying Facies"
NCT07802639Hemifacial Microsomia, Facial Nerve Paralysis
Peking Union Medical College
Not applicable
60
Beijing
2026-08-07
Recruiting
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
NCT07498335Berger Disease, Bergers Disease, IgA Nephropathy, Immunoglobulin A Nephropathy
Novartis Pharmaceuticals
Phase 3
28
Beijing
2026-08-06
Recruiting
OverStitch NXT Endoscopic Suture System
NCT07276815Weight Loss
Boston Scientific Corporation
Not applicable
136
Beijing
2026-08-06
Recruiting
Establishment of a Multi-omics Prediction Model for Early Triple-negative Breast Cancer Based on UPGRADE-TNBC Study
NCT07773818Triple -Negative Breast Cancertriple, Meta-Learning, Predictive Models, Multimodal
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
32
Beijing
2026-08-06
Not yet open
QT Interval Effects Study of Oral FXS5626 Tablets
NCT07695779Evaluation of QTc Interval
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Phase 1
28
Beijing
2026-08-05
Recruiting
Perioperative Transcranial Photobiomodulation and Delayed Neurocognitive Recovery in Older Patients
NCT07736092Older Adults, Surgery, Transcranial Photobiomodulation, Delayed Neurocognitive Recovery
Peking University First Hospital
Not applicable
130
Beijing
2026-08-05
Recruiting
A Study of HS-10566 in Patients With High-risk Non-muscle-invasive Bladder Cancer Who Are Ineligible for or Refuse Radical Cystectomy
NCT07468851High-risk Non-muscle-invasive Bladder Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1/2
180
Beijing, Nanjing
2026-08-05
Not yet open
Epidural Spinal Cord Stimulation for Respiratory Recovery in Brain Injury
NCT07766681Brain Injuries, Respiratory Failure
Zhongda Hospital
Not applicable
10
Beijing, Nanjing, Suzhu
2026-08-05
Recruiting
A Phase III Clinical Study to Evaluate the Efficacy and Safety of MH004 Ointment in Non-segmental Vitiligo
NCT07682506Vitiligo
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 3
405
Beijing
2026-08-04
Not yet open
Phase โ…ข Clinical Trial to Evaluate the Efficacy and Safety of TJ0113 Capsules in Patients With Early-Onset Parkinson's Disease
NCT07741045Parkinson's Disease (PD), Parkinson Disease 6, Early-Onset
Hangzhou PhecdaMed Co., Ltd.
Phase 3
300
Beijing, Chongqing, Guangzhou, Zhengzhou, Wuhan, Changsha, Suzhou, Shanghai
2026-08-03
Recruiting
Phase โ… /โ…กa Trial Evaluating Intravenous hUC-MSCs Injection for Safety, Tolerability and Efficacy in Patients With POI
NCT07775391Premature Ovarian Insufficiency
Shenzhen Wingor Biotechnology Co., Ltd.
Phase 1/2
59
Beijing
2026-08-03
Not yet open
an Analgesia-first Strategy Without Hypnotic Sedatives in Adult Patients Admitted to the Intensive Care Unit After Neurosurgical Craniotomy
NCT06727435Craniotomy, Neurosurgical Patients
Beijing Tiantan Hospital
Not applicable
65
Beijing
2026-08-01
Not yet open
Neoadjuvant Disitamab Vedotin, Toripalimab, and Radiotherapy for High-risk UTUC ( LUXUS07.1 )
NCT07720921Urothelial Carcinoma of the Renal Pelvis and Ureter, Neoadjuvant Therapy
Peking University First Hospital
Phase 2
20
Beijing
2026-08-01
Not yet open
Evaluation of NWRD09 for HPV-16 Related Cervical HSIL
NCT07712692High-grade Squamous Intraepithelial Lesion (HSIL)
Newish Biotech (Wuxi) Co., Ltd.
Phase 2
156
Beijing, Chongqing, Lanzhou, Baoding, Zhengzhou, Nanjing, Changchun, Jinan
2026-08-01
Not yet open
Prospective Collection and Registry Study of Multicenter, Multidisciplinary Surgical Minimally Invasive Videos
NCT07752862Surgical Neoplasms, Abdominal Surgical Diseases, Pelvic Surgical Diseases, Urologic Surgical Diseases
Chinese Academy of Sciences
Observational
2,000
Beijing
2026-08-01
Not yet open
Speech-to-speech Voice-cloning Care (SVCC) to Improve ICU-acquired Anxiety for Critically Ill Patients
NCT06743321Critical Care Nursing
Peking Union Medical College Hospital
Not applicable
234
Beijing
2026-08-01
Not yet open
Intelligent Microcatheter Shaping for Intracranial Aneurysm Coil Embolization
NCT07749404Intracranial Aneurysm
Xuanwu Hospital, Beijing
Observational
1,438
Beijing
2026-08-01
Recruiting
Perioperative Statins to Prevent AFib After Lung Surgery
NCT07727681Postoperative Atrial Fibrillation, Lung Surgery
Peking Union Medical College Hospital
Phase 4
540
Beijing
2026-08-01
Recruiting
Comprehensive Assessment System for Fallopian Tube Function and Clinical Study on Individualized Treatment Strategies
NCT07808229Multidimensional Tubal Function Assessment and Individualized Treatment Strategies for Tubal Factor Infertility
Peking University People's Hospital
Not applicable
240
Beijing
2026-08-01
Not yet open
Research on the Efficacy and Mechanism of Shouhui Tongbian Capsules in Treating Postoperative Constipation of Benign Anal and Rectal Diseases Based on Gut Microbiota Analysis
NCT07648394Intestinal Flora, Anorectal Diseases, Surgery, Constipation
China-Japan Friendship Hospital
Phase 1/2
120
Beijing
2026-08-01
Not yet open
Tenecteplase or Reteplase as Bridging Thrombolysis Before Thrombectomy in Acute Ischemic Cerebrovascular Events
NCT07748039Acute Ischemic Stroke, Large Vessel Occlusion, Anterior Circulation Brain Infarction
Yongjun Wang
Phase 3
1,440
Beijing, Wuhan, Xiangtan, Rizhao, Ya'an
2026-08-01
Not yet open
Prophylactic IABP in Delayed-Presentation Anterior STEMI
NCT07761455Acute Anterior ST-Segment Elevation Myocardial Infarction
Qilu Hospital of Shandong University
Not applicable
504
Jinan, Jining, Qingdao, Beijing
2026-08-01
Not yet open
Micro-axial Flow Pump-Supported PCI in Complex Coronary Artery Disease With Ischemic LV Dysfunction
NCT07678021Coronary Artery Disease (CAD)
China National Center for Cardiovascular Diseases
Not applicable
452
Beijing
2026-08-01
Not yet open
Development and Validation of a Risk Prediction Model for Cardiac Surgery-associated Acute Kidney Injury Based on the Gut-Kidney Axis, Incorporating Gut Microbiota and Their Metabolites
NCT07738796Acute Kidney Injury After Adult Cardiac Surgery, Gastrointestinal Microbiome, Metabolome, Risk Assessment
Peking Union Medical College Hospital
Observational
182
Beijing
2026-08-01
Not yet open
Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEF
NCT07630454Atrial Fibrillation, Heart Failure With Preserved Ejection Fraction (HFpEF), Tirzepatide
Yunlong Wang
Phase 4
602
Beijing
2026-08-01
Not yet open
A Phase 2 Study of Sirolimus for Injection (Albumin-bound) in Patients With Progressive or Symptomatic Epithelioid Hemangioendothelioma
NCT07684287Epithelioid Hemangioendothelioma
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 2
40
Beijing
2026-08-01
By invitation
Long-Term Follow-Up Study for RB001 Gene Therapy Study in Children With SHANK3-related Phelan McDermid Syndrome (PMS)
NCT07690527SHANK3 Haploinsufficiency, Phelan-McDermid Syndrome
Peking University First Hospital
Phase 1
8
Beijing
2026-08-01
Not yet open
The Impact of Multimodal Brain Monitoring on Postoperative Outcomes in Elderly Patients Undergoing Major Abdominal Surgery
NCT07713355Anesthesia, General, Major Abdominal Surgeries
Xuanwu Hospital, Beijing
Not applicable
368
Beijing, Zhengzhou, Wuhan
2026-08-01
Not yet open
Evaluating the Efficacy and Safety of Daridorexant Transition From BZRAs in Insomnia Patients๏ผˆEASY-TIP๏ผ‰
NCT07733414Insomnia Disorders
Xuanwu Hospital, Beijing
Phase 4
156
Beijing
2026-08-01
Not yet open
A Study on the Consistency Evaluation of Digital PCR Technology for Quantitative Detection of HBV Nucleic Acid
NCT07684209Chronic Hepatitis b
Beijing Municipal Administration of Hospitals
Observational
200
Beijing
2026-08-01
Not yet open
AI-assisted Rare Disease Diagnosis
NCT07650799Rare Disorders, Rare Diseases
Peking Union Medical College Hospital
Not applicable
1,056
Beijing, Cangzhou, Changchun, Dongguan, Foshan, Guiyang, Jilin City, Kunming
2026-08-01
Not yet open
Efficacy and Safety of Utidelone Capsule and Utidelone Injection in Patients With HER-2 Negative Advanced Breast Cancer
NCT07684456Advanced Breast Cancer
Beijing Biostar Pharmaceuticals Co., Ltd.
Phase 3
308
Beijing
2026-08-01
Not yet open
Efficacy and Safety of Lenalidomide in Patients With IgG4-Related Disease
NCT07719543Immunoglobulin G4-Related Disease
Chinese PLA General Hospital
Phase 3
146
Beijing, Sanya, Wuhan
2026-08-01
Not yet open
Safety and Efficacy of Microwave Ablation Alone Versus Microwave Ablation Combined With Chemical Ablation in the Treatment of Uterine Fibroids: A Prospective, Multicenter Study
NCT07754877Uterine Fibroids (UF), Microwave Ablation, Ultrasound
Peking University Aerospace Center Hospital
Not applicable
248
Beijing
2026-08-01
Not yet open
Study on Clinicopathological Features, Influencing Factors and Clinical Outcomes in Patients With PSVD
NCT07744048Porto-Sinusoidal Vascular Diseases
Beijing Municipal Administration of Hospitals
Observational
150
Beijing
2026-08-01
Not yet open
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CT
NCT07762755Coronary Artery Disease, Hyperlipidaemia, Hypertriglyceridaemia, Coronary Atherosclerosis
China National Center for Cardiovascular Diseases
Phase 4
100
Beijing
2026-08-01
Not yet open
A Prospective Multicenter Real-World Registry of Quantitative Flow Ratio-Guided Coronary REvascularization and QuAlity evaLuation
NCT07766434Coronary Artery Disease
China National Center for Cardiovascular Diseases
Observational
10,000
Beijing
2026-08
Not yet open
Fire Needling Plus Filiform Needling for Chronic Migraine With Comorbid Tension-Type Headache
NCT07633522Chronic Migraine, Tension-type Headache
Beijing Hospital of Traditional Chinese Medicine
Not applicable
88
Beijing
2026-08
Not yet open
A Phase II Study of TollB-001 Tablets in Systemic Sclerosis
NCT07745725Systemic Sclerosis (SSc)
Toll Biotech Co. Ltd. (Beijing)
Phase 2
36
Beijing
2026-08
Not yet open
Study on Clinical and Pathological Features of Primary Biliary Cholangitis and Risk Factors Related to Disease Progression
NCT07733882PBC
Beijing Municipal Administration of Hospitals
Observational
300
Beijing
2026-08
Not yet open
Integrated Prevention, Treatment, and Rehabilitation for Toileting-Related Falls
NCT07738354Toileting-Related Falls, Fall Risk
Qing Yuan
Not applicable
300
Beijing
2026-08
Not yet open
Trientine Tetrahydrochloride Administered Once a Day for the First Line Treatment of Wilson's Disease Patients.
NCT07465718Wilson's Disease
Orphalan
Phase 3
38
Beijing, Hangzhou
2026-08
Not yet open
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
NCT07759245Pulmonary Disease, Chronic Obstructive
Eli Lilly and Company
Phase 2
606
Baotou, Beijing, Chengdu, Guangzhou, Jiangyin, Jinan, Pingxiang, Shanghai
2026-08
Not yet open
Remimazolam Versus Propofol for Maintenance of Anaesthesia During Major Hepatectomy Under Low Central Venous Pressure
NCT07789275Intraoperative Hypotension, Hepatectomy
Beijing Tsinghua Chang Gung Hospital
Phase 4
224
Beijing
2026-08
Not yet open
A Study of SI-B036 in Patients With Locally Advanced or Metastatic Urological Tumors and Other Solid Tumors
NCT07744243Urological Cancer, Solid Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
30
Beijing
2026-08
Not yet open
A Study of LAE118 as Monotherapy and in Combination With Antitumor Agents in Advanced Solid Tumors
NCT07787520Patients With Advanced Solid Tumors
Laekna Limited
Phase 1
150
Hefei, Beijing, Changchun, Shanghai, Hangzhou
2026-08
Not yet open
A Study of MRG007 Combination Therapy for Advanced Colorectal Cancer
NCT07737600Advanced Colorectal Cancer
Lepu Biopharma Co., Ltd.
Phase 1/2
316
Beijing
2026-08
Not yet open
Sodium Oxybate for Postoperative Sleep Disturbance After Thoracic Surgery
NCT07794982Thoracic Surgical Procedures
Jingsheng Lou
Not applicable
360
Beijing
2026-08
Recruiting
Transcutaneous Auricular Vagus Nerve Stimulation for Recovery of Consciousness After Surgery for Spontaneous Intracerebral Hemorrhage
NCT07761507Disorders of Consciousness, Spontaneous Intracerebral Hemorrhage
Beijing Tiantan Hospital
Not applicable
160
Beijing
2026-08
Recruiting
A Study of Rocbrutinib in PRL-Positive Relapsing-Remitting Multiple Sclerosis
NCT07776743Relapsing-remitting Multiple Sclerosis (RRMS)
Guangzhou Lupeng Pharmaceutical Company LTD.
Phase 2
30
Beijing
2026-08
Not yet open
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
NCT07775300Depressive Disorder, Major
Eli Lilly and Company
Phase 3
1,000
Beijing, Chaohu, Jinan, Linfen, Shanghai, Suzhou, Tianjin, Wenzhou
2026-08
Recruiting
A Clinical Trial to Evaluate the Efficacy and Safety of HL-1186 Tablet in the Treatment of Postherpetic Neuralgia
NCT07758920Postherpetic Neuralgia ( PHN )
Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
Phase 2
200
Beijing
2026-08
Not yet open
A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Membranous Nephropathy
NCT07765537Primary Membranous Nephropathy
Shenzhen Fosun Kairos Biotechnology Co., Ltd.
Phase 1/2
55
Hefei, Beijing, Guangzhou, Shenzhen, Wuhan, Changsha, Nanjing, Chengdu
2026-08
Not yet open
Fuyang Jiedu Granules Plus Antiretroviral Therapy for HIV Immune Non-Responders With Spleen-Kidney Yang Deficiency
NCT07698548HIV-1 Infection, Acquired Immunodeficiency Syndrome, Immune Reconstitution Failure, Immunological Non-responder
Beijing University of Chinese Medicine
Not applicable
240
Beijing
2026-08
Not yet open
Dexmedetomidine-Esketamine Combination on Depression and Anxiety After Laparoscopic Ureteral Reconstruction
NCT07753772Ureteral Stricture, Dexmedetomidine, Esketamine, Depressive Symptoms
Peking University First Hospital
Phase 4
658
Beijing
2026-08
Not yet open
A Phase 3 Trial of DR10624 Versus Placebo in Patients With Severe Hypertriglyceridemia
NCT07680829Severe Hypertriglyceridemia
Zhejiang Doer Biologics Co., Ltd.
Phase 3
378
Beijing
2026-08
Not yet open
Qiling Yiqi Tablets Plus Antiretroviral Therapy for HIV Immune Non-responders With Lung-Spleen Qi Deficiency
NCT07698574HIV-1 Infection, Acquired Immunodeficiency Syndrome, Immune Reconstitution Failure, Immunological Non-responder
Beijing University of Chinese Medicine
Not applicable
240
Beijing
2026-08
Not yet open
PRECISE-AFMR I: Transcatheter Mitral Valve Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation in Patients at High Surgical Risk
NCT07741253Atrial Functional, Mitral Regurgitation (MR)
China National Center for Cardiovascular Diseases
Not applicable
182
Beijing
2026-08
Not yet open
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of HDM1005 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Not Receiving Positive Airway Pressure (PAP) Therapy
NCT07787260Obstructive Sleep Apnea (OSA) and Obesity
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 3
200
Beijing
2026-08
Not yet open
Remimazolam Versus Propofol for Early Recovery After Cytoreductive Surgery
NCT07785557Peritoneal Neoplasms, Postoperative Recovery
Beijing Tsinghua Chang Gung Hospital
Not applicable
320
Beijing
2026-08
Recruiting
IN10018 in Combination With Dalpiciclib for Progressive Meningiomas
NCT07652762Meningioma, CDK4/6 Inhibitor
Capital Medical University
Phase 1
24
Beijing
2026-08
Not yet open
Phase III Study of OT202 in Treating Moderate to Severe Dry Eye
NCT07740564Dry Eye
Ocumension Therapeutics (Suzhou) Co., Ltd
Phase 3
842
Bengbu, Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Guangzhou, Shantou
2026-08
Not yet open
Fascia Iliaca Block Using Liposomal Bupivacaine for Analgesia After Hip Surgery
NCT07643792Fascia Iliaca Block, Liposomal Bupivacaine, Postoperative Pain, Hip Surgery
Peking University First Hospital
Phase 4
148
Beijing
2026-08
Not yet open
A Study to Evaluate the Efficacy and Safety of ICP-488 in Participants With Primary Sjรถgren's Syndrome
NCT07727486Primary Sjรถgren's Syndrome
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 2
240
Beijing, Chongqing, Xiamen, Guangzhou, Nanning, Shijiazhuang, Changsha, Zhuzhou
2026-08
Not yet open
Phase I Clinical Study Evaluating the Relative Bioavailability of Different Formulations of HRS-5346 in Healthy Participants
NCT07752069Lipoprotein Disorder
Shandong Suncadia Medicine Co., Ltd.
Phase 1
50
Beijing
2026-08
Not yet open
Diagnostic Accuracy and Safety of the Attention-Deficit/Hyperactivity Disorder Auxiliary Evaluation System (AHEF) in Chinese Children Aged 6 to 12
NCT07683156Attention-Deficit, Hyperactivity Disorder
Chongqing Jinsaixing Medical Technology Co., Ltd
Observational
570
Beijing, Chongqing, Guangzhou, Shenzhen, Nanjing, Changchun, Shanghai, Chengdu
2026-07-31
Recruiting
Ultra-early Identification of Futile Recanalization After Reperfusion Therapy in Acute Ischemic Stroke Based on Cerebral Autoregulation Monitoring
NCT07747701Acute Ischemic Stroke, Cerebral Autoregulation
Beijing Shijitan Hospital, Capital Medical University
Not applicable
227
Beijing, Dalian, Heilongjiang, Shandong
2026-07-31
Not yet open
A Randomized Controlled Trial of Autostereoscopic 3D Vision Therapy for Amblyopia
NCT07709832Amblyopia, Visual Training, Visual Functions, Visual Health
Beijing Tongren Hospital
Not applicable
34
Beijing
2026-07-31
Not yet open
Efficacy and Safety of Brentuximab Vedotin Combined With Lisaftoclax in CD30+ Cutaneous T-cell Lymphoma (CTCL)
NCT07717580Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Primary Cutaneous Anaplastic Large Cell Lymphoma
Peking University First Hospital
Phase 2
46
Beijing
2026-07-31
Recruiting
Comparing ICI Followed By CCRT And CCRT Followed By Immunotherapy In Unresectable LA-ESCC
NCT07733830Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2
120
Beijing, Zhengzhou, Shenyang, Taiyuan, Chengdu, Tianjin
2026-07-31
Not yet open
UBT251 Injection Phase โ…ข Study (Overweight or Obesity)
NCT07648225Obesity & Overweight
The United Bio-Technology (Hengqin) Co., Ltd.
Phase 3
600
Beijing
2026-07-31
Not yet open
Evaluating Safety and Efficacy of VV119 in Acute Schizophrenia Adults
NCT07703956Schizophrenia
Vigonvita Life Sciences
Phase 2
500
Beijing
2026-07-31
Recruiting
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
NCT07521007Atherosclerosis, Coronary Artery Disease
Beijing Inno Medicine Co., Ltd.
Phase 2
456
Hefei, Beijing, Fuzhou, Lanzhou, Guangzhou, Harbin, Wuhan, Changsha
2026-07-31
Not yet open
Luvometinib in Combination With Serplulimab for NF2-Related Tumors
NCT07708285NF2-related Schwannomatosis, NF2, Neurofibromatosis Type 2, Vestibular Schwannoma
Beijing Tiantan Hospital
Phase 1/2
30
Beijing, Changchun, Shanghai
2026-07-31
Not yet open
Huanghou Zhixie Diwan in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D)
NCT07721012Patients With Irritable Bowel Syndrome With Diarrhea
Lei Yunshang Group
Phase 2
120
Beijing, Changsha, Daqing, Guangzhou, Hohhot, Lianyungang, Luoyang, Meihekou
2026-07-31
Not yet open
SLNB Combined With WLNB for Axillary De-escalation in Breast Cancer Patients With Abnormal Axillary Nodes
NCT07791771Breast Cancer
Peking University Cancer Hospital & Institute
Observational
84
Beijing
2026-07-31
Not yet open
A Study on the Novel Oncolytic Virus Combined With PD-1 Inhibitor in the Treatment of Recurrent High-grade Glioma
NCT07472790High-grade Glioma
Beijing Bio-Targeting Therapeutics Technology Co., Ltd
Phase 1
15
Beijing
2026-07-31
Recruiting
First-in-Human Trial of VBC108 in Participants With Advanced Malignant Solid Tumors
NCT07700160Advanced Solid Tumors
VelaVigo Bio Inc
Phase 1/2
230
Beijing, Shanghai, Hangzhou
2026-07-30
Not yet open
A Phase IIa Study of JAB-8263 in Patients With Active Rheumatoid Arthritis
NCT07684157Rheumatoid Arthritis (RA)
Jacobio Pharmaceuticals Co., Ltd.
Phase 2
32
Beijing
2026-07-29
Recruiting
A Study of LM-168 Combined With Other Anti-tumor Treatments in Participants With Advanced Solid Tumors
NCT07669415Advanced Solid Tumor
LaNova Medicines Limited
Phase 2
108
Beijing
2026-07-29
Recruiting
A Study of MI226 Injection for Abdominal Fat Accumulation
NCT07749742Abdominal Fat
Nanjing Minova Pharmaceutical Co., Ltd.
Phase 1
52
Beijing
2026-07-28
Not yet open
SHR-A1904 in Advanced Colorectal Cancer: an Exploratory Study
NCT07700719Colorectal Cancer Metastatic
Peking University Cancer Hospital & Institute
Phase 2
17
Beijing
2026-07-28
Not yet open
Phase 1 Clinical Study of GenSci155 Injection in Healthy Adults
NCT07638800Healthy Adult Trial Participants
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
68
Beijing
2026-07-28
Recruiting
A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
NCT07725939Chronic Obstructive Pulmonary Disease With Chronic Bronchitis
UCB Biopharma SRL
Phase 2
402
Beijing, Chengdu, Hangzhou, Nanchang
2026-07-27
Rows per page Showing 201–300 of 5484
Previous 1 2 3 4 5 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china/city/beijing?page=3

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 5,484 of those studies with a site in Beijing.

How many clinical trials are recruiting in Beijing?

3,341 of the 5,484 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 966 have not yet opened recruitment, 1,001 are active but closed to new participants, and 176 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.